Fact CheckerSign in

NCT06400290Recruiting

Multivessel Balloon Occlusion to Investigate Obstructive Coronary Artery Disease and aNgina

Source: ClinicalTrials.gov · Last updated 28 Oct 2026

Brief summary (registry, in English)

ORBITA-MOON is a double-blinded, placebo-controlled experimental study that aims to understand how the different coronary artery stenoses contribute to overall clinical angina in patients with multi-vessel coronary artery disease. This study will investigate the symptoms conferred by each stenosis, induced by experimental ischaemia, for 50 patients with multi-vessel coronary artery disease.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
50 (estimated)
First submitted
24 Apr 2024
Start date
13 Jun 2024
Primary completion date
Jan 2027
Lead sponsor
Imperial College London
NCT number
NCT06400290

What you commit to

  • Study type: Interventional
  • Planned participants: 50
  • From 13 Jun 2024 to the primary completion date, Jan 2027
  • 8 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous coronary artery by-pass graft surgery (CABG)
  • Contraindication to PCI or a drug-eluting stents
  • Contraindication to antiplatelet therapy

Other illness

  • Recent acute coronary syndrome
  • Significant left main stem disease
  • Moderate to severe valvular disease
  • Moderate to severe left ventricular impairment

Other

  • Chronic total occlusion in the target artery(s)
  • Contraindication to adenosine
  • Pregnant
  • Inability to consent

Who the study is looking for

  • Eligibility for PCI due to angina
  • Anatomical evidence of significant multi-vessel coronary stenosis defined by either:
    • ≥70% stenosis in two or more coronary arteries of ≥2.5mm visual diameter stenosis, on invasive coronary angiography (ICA)
    • Severe stenosis in ≥2 coronary arteries of ≥ 2.5mm visual diameter stenosis, on CTCA
  • Physiological evidence of ischaemia with a positive test corresponding to the coronary arteries to be stented, on at least one of the following:
    • dobutamine stress echocardiogram
    • cardiac MRI
    • myocardial perfusion study
    • CT-FFR
    • invasive metrics of coronary physiology

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (8)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Essex Cardiothoracic Centre
Coordinator of this site? Confirm its status
BasildonUnited KingdomRecruiting
Royal Bournemouth Hospital
Coordinator of this site? Confirm its status
BournemouthUnited KingdomRecruiting
Royal Sussex County Hospital
Coordinator of this site? Confirm its status
BrightonUnited KingdomRecruiting
Imperial College NHS Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
Royal Free London NHS Foundation Trust
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
St Georges University Hospital
Coordinator of this site? Confirm its status
LondonUnited KingdomRecruiting
Portsmouth Hospitals University NHS Trust
Coordinator of this site? Confirm its status
PortsmouthUnited KingdomNot yet recruiting
University Hospital Southampton
Coordinator of this site? Confirm its status
SouthamptonUnited KingdomRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.